CVS Health is a medical - healthcare plans company in the healthcare sector trading on NYSE, led by CEO J. David Joyner, with a market cap of $97.6B.
Upcoming earnings announcement for CVS Health
Past 12 earnings reports for CVS Health
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 10, 2026 | Q4 2025 | $1.09Est: $0.99 | +10.1% | $105.69BEst: $103.52B | +2.1% | |
| Oct 29, 2025 | Q3 2025 | $1.60Est: $1.36 | +17.6% | $102.87BEst: $98.6B | +4.3% | |
| Jul 31, 2025 | Q2 2025 | $1.81Est: $1.47 | +23.1% | $98.9BEst: $94.2B | +4.9% | |
| May 1, 2025 | Q1 2025 | $2.25Est: $1.70 | +32.4% | $94.6BEst: $93.6B | +1.0% | |
| Feb 12, 2025 | Q4 2024 | $1.19Est: $0.93 | +27.5% | $97.7BEst: $97.2B | +0.5% | |
| Nov 6, 2024 | Q3 2024 | $1.09Est: $1.53 | -28.8% | $95.4BEst: $92.8B | +2.9% | |
| Aug 7, 2024 | Q2 2024 | $1.83Est: $1.73 | +5.8% | $91.2BEst: $91.5B | -0.3% | |
| May 1, 2024 | Q1 2024 | $1.31Est: $1.69 | -22.5% | $88.4BEst: $89.2B | -0.9% | |
| Feb 7, 2024 | Q4 2023 | $2.12Est: $1.99 | +6.5% | $93.8BEst: $90.4B | +3.8% | |
| Nov 1, 2023 | Q3 2023 | $2.21Est: $2.13 | +3.8% | $89.8BEst: $88.3B | +1.7% | — |
| Aug 2, 2023 | Q2 2023 | $2.21Est: $2.12 | +4.2% | $88.9BEst: $86.7B | +2.5% | |
| May 3, 2023 | Q1 2023 | $2.20Est: $2.09 | +5.3% | $85.3BEst: $81.0B | +5.3% | — |
We use cookies for analytics. See our Privacy and Cookie Policy.